« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 14, Issue 12
, Pages 1394-1400
, December 2008
Allogeneic Hematopoietic Stem Cell Transplantation in Adult Acute Lymphocytic Leukemia: Impact of Donor Source on Survival
References
- In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood. 2008;111:1827–18331
- Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?. Blood. 2003;101:4233–4244
- Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342:1846–1854
- Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 2001;97:2962–2971
- Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood. 2001;97:2957–2961
- Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol. 2004;124:488–498
- . Umbilical cord blood versus marrow: The search process. Biol Blood Marrow Transplant. 2004;10:735
- Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815–1822
- Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood. 2001;98:2332–2338
- Unrelated cord blood transplantation for adult patients with advanced myelodysplastic syndrome. Blood. 2003;101:4711–4713
- Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997;337:373–381
- Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–1577
- Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003;102:1915–1919
- Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact on transplant outcomes in 110 adults with hematological disease. Blood. 2007;110:3064–3070
- . Double umbilical cord blood transplantation. Curr Opin Immunol. 2006;18:571–575
- . Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
- . Regression models and life tables. J R Soc B. 1972;34:187–220
- . Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med. 1997;16:901–910
- . Handbook of Parametric and Nonparametric Statistical Procedures. London: Chapman & Hall; 2000;CRC
- . Statistical Methods. 8th ed. Ames, IA: Iowa State University Press; 1989;
- Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood. 2007;109:944–950
- Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol. 2004;22:4075–4086
- Outcome of allogeneic hematopoietic stem-cell transplantation in adults patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol. 2004;22:2816–2825
- Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood. 2004;104:3028–3037
- Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. Blood. 1995;86:1619–1628
- The outcome of 551 1st CR transplants in adult ALL from the MRC UKALL XII/ECOG E2933 study. ASH Annual Meeting Abstracts. Blood. 2004;104:615
- Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. Biol Blood Marrow Transplant. 2002;8:213–220
- Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 1997;90:1410–1414
- Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood. 2008;112:426–434
- Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–2285
- Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor. Bone Marrow Transplantation. 2007;40:339–347
- A potential graft- versus -leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society. Bone Marrow Transplant. 2003;31:909–918
Financial disclosure: See Acknowledgments on page 1399.
PII: S1083-8791(08)00420-5
doi: 10.1016/j.bbmt.2008.09.021
© 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 14, Issue 12
, Pages 1394-1400
, December 2008
